The Medicines Company was acquired by Novartis for $9.7 billion despite having no revenue (versus $600 million for Amarin) and...
amrn stock
The 7 analysts offering 12-month price forecasts for Amarin Corporation PLC have a median target of 10.00, with a high...
Out of 2 analysts, 0 (0%) are recommending AMRN as a Strong Buy, 1 (50%) are recommending AMRN as a...
